Ferndale Healthcare®, Inc., a company celebrated for meeting the changing needs of patients and healthcare professionals, is pleased to announce a three year partnership on behalf of its RectiCare® (Lidocaine 5%) Anorectal Cream brand and the Colon Cancer Alliance, www.ccalliance.org. This non-profit corporation is the nation’s leading patient advocacy organization dedicated to increasing colon cancer screening rates and survivorship.
In support of the partnership, RectiCare® will implement various promotional efforts to help educate and raise awareness of colon cancer among consumers of all ages, alerting them to signs and symptoms of the third most prevalent cancer in the United States. “Consumers experiencing symptoms such as bleeding, soreness and pain are often tempted to self-treat using a variety of over-the-counter preparations. They believe they have hemorrhoids, fissures, or other very common anal-rectal maladies,” commented Katherine Gunn, Product Manager for RectiCare®.
Photo credit: RectiCare“Of course, we want to sell our brand, but we believe it is also our responsibility to encourage consumers to see their Physicians to rule out a serious underlying disease, such as colon cancer,” continued Gunn. “RectiCare is designed to manage the symptoms of benign anorectal conditions, helping to soothe and calm discomfort and pain.” RectiCare® is a topical, local anesthetic cream, which contains the highest lidocaine strength available without a prescription. Recommended by Colon and Rectal Surgeons nationwide, RectiCare® works quickly to help relieve pain, itching and burning associated with hemorrhoids and other anorectal disorders.
Through this partnership, RectiCare® hopes to further the mission of the Colon Cancer Alliance and help end the suffering caused by colon cancer. In addition to generating awareness and educating consumers on this devastating disease, over the next three years, RectiCare® is providing financial support to benefit the lifesaving programs of the Colon Cancer Alliance. Plans to add the Colon Cancer Alliance logo to the RectiCare® website, product packaging, and collateral materials are currently in-the-works. For more information, please visit www.recticare.com or www.ferndalehealthcare.com.
About Ferndale Healthcare®, Inc.:
Ferndale Healthcare®, Inc. is an affiliate of Ferndale Pharma Group Inc., a fully integrated holding company. Ferndale Healthcare® targets several key specialty markets which encompass disease states that range from benign anorectal disorders to various skin conditions. The company’s mission is to provide high-quality, value-added products that help patients get back to what matters most in their lives—living well. Many of Ferndale Healthcare’s products are leaders in their respective categories.
About The Colon Cancer Alliance (CCA):
The Colon Cancer Alliance, Inc. is a not-for-profit 501(c)3 corporation (EIN 86-0947831). The Colon Cancer Alliance’s mission is to knock colon cancer out of the top three cancer killers. This mission is being accomplished by championing prevention, funding cutting-edge research and providing the highest quality patient support services. Learn more at ccalliance.org.
